Posted On 31-07-2025

• Rising Prevalence of Chronic Diseases: The growing incidence of chronic diseases such as diabetes, cardiovascular diseases, and kidney disorders is propelling the demand for advanced diagnostic testing solutions in North America. Companies like Abbott Laboratories have reported an increase in the adoption of their clinical chemistry analyzers due to the greater need for routine metabolic and biochemical testing for chronic disease management.
• Advancements in Automation and Integration: Leading players such as Roche Diagnostics are at the forefront of integrating automation and IT in clinical laboratories. Automation in chemistry analyzers reduces errors, increases throughput, and enables laboratories to manage higher volumes of tests more efficiently, supporting market growth and adoption across hospital and reference labs.